Benzinga's Top Downgrades

Morgan Keegan downgraded Abbott Laboratories ABT from “outperform” to “market perform.” ABT's shares closed at $50.51 yesterday. Abbott Laboratories' trailing-twelve-month ROA is 8.03%. Pacific Sunwear of California Inc PSUN was downgraded by Oppenheimer from "outperform" to "perform." PSUN's shares closed at $2.17 yesterday. Pacific Sunwear's trailing-twelve-month ROE is -42.17%. Analysts at Morgan Keegan downgraded Boston Scientific Corporation BSX from “outperform” to “market perform.” BSX's stock closed at $6.34 yesterday. Boston Scientific's trailing-twelve-month profit margin is 7.91%. Deutsche Bank downgraded United Therapeutics Corp UTHR from “buy” to “hold.” UTHR's shares closed at $48.76 yesterday. United Therapeutics' trailing-twelve-month revenue is $689.46 million.